Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis

Background:  The aim of the study was to assess autoimmune involvement in amyotrophic lateral sclerosis (ALS). Methods:  We measured IgG antibodies against light (NFL) and medium (NFM) subunits of neurofilaments using ELISA in paired cerebrospinal fluid (CSF) and serum samples from 38 ALS patients a...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of neurology Vol. 17; no. 4; pp. 562 - 566
Main Authors Fialová, L., Švarcová, J., Bartos, A., Ridzoň, P., Malbohan, I., Keller, O., Rusina, R.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.04.2010
John Wiley & Sons, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background:  The aim of the study was to assess autoimmune involvement in amyotrophic lateral sclerosis (ALS). Methods:  We measured IgG antibodies against light (NFL) and medium (NFM) subunits of neurofilaments using ELISA in paired cerebrospinal fluid (CSF) and serum samples from 38 ALS patients and 20 controls. Results:  Serum levels of anti‐NFL were higher in ALS patients than in controls (P < 0.005). Serum anti‐NFL antibodies and intrathecal anti‐NFM antibodies were related to patient disability (serum anti‐NFL: P < 0.05; intrathecal anti‐NFM: P < 0.05). Anti‐NFL levels were significantly correlated with anti‐NFM levels in ALS (P < 0.001) and the control group (P < 0.0001) in the CSF, but not in serum. Anti‐NFL and anti‐NFM antibodies significantly correlated between serum and CSF in the ALS group (anti‐NFL: P < 0.0001; anti‐NFM: P < 0.001) and in the control group (anti‐NFL: P < 0.05; anti‐NFM: P < 0.05). Conclusions:  Autoimmune humoral response to neurocytoskeletal proteins is associated with ALS.
Bibliography:istex:AEC102915881CBD8820015F2385CEDBE541001DF
ark:/67375/WNG-JVFCK1DG-G
ArticleID:ENE2853
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1351-5101
1468-1331
DOI:10.1111/j.1468-1331.2009.02853.x